Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicky A Cameron

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
BMC Pediatrics|August 6, 2015
The New Zealand 1986 very low birth weight cohort as young adults: mapping the road aheadBrian A Darlow, L John Horwood, Lianne J Woodward, et al.
BMC Cardiovascular Disorders|August 17, 2018
Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromesEdward C A Marks, Tom M Wilkinson, Chris M Frampton, et al.
Journal of Cardiac Failure|March 14, 2013
The Singapore Heart Failure Outcomes and Phenotypes (SHOP) study and Prospective Evaluation of Outcome in Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction (PEOPLE) study: rationale and designRajalakshmi Santhanakrishnan, Tze P Ng, Vicky A Cameron, et al.
The New Zealand Medical Journal|August 18, 2018
Genomic medicine must reduce, not compound, health inequities: the case for hauora-enhancing genomic resources for New ZealandStephen P Robertson, Jennie Harre Hindmarsh, Sarah Berry, et al.
Heart (British Cardiac Society)|February 14, 2023
Prognostic modelling of clinical outcomes after first-time acute coronary syndrome in New ZealandNikki J Earle, Katrina K Poppe, Anna Rolleston, et al.
Atherosclerosis|September 17, 2025
Lipoprotein(a) concentrations and secondary outcomes following first-time acute coronary syndrome: The Multi-Ethnic New Zealand Study of Acute Coronary Syndromes (MENZACS)Malcolm E Legget, Nikki J Earle, Katrina K Poppe, et al.
Journal of the American College of Cardiology|March 23, 2019
Combining Circulating MicroRNA and NT-proBNP to Detect and Categorize Heart Failure SubtypesLee Lee Wong, Ruiyang Zou, Lihan Zhou, et al.
Journal of the American College of Cardiology|January 29, 2013
Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysisKenneth Chan, Riyaz S Patel, Paul Newcombe, et al.
European Heart Journal|March 22, 2021
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortalityStefan J Schunk, Marcus E Kleber, Winfried März, et al.
Circulation|July 14, 2020
Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant DataBakhtawar K Mahmoodi, Vinicius Tragante, Marcus E Kleber, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
BMC Pediatrics|August 6, 2015
The New Zealand 1986 very low birth weight cohort as young adults: mapping the road aheadBrian A Darlow, L John Horwood, Lianne J Woodward, et al.
BMC Cardiovascular Disorders|August 17, 2018
Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromesEdward C A Marks, Tom M Wilkinson, Chris M Frampton, et al.
Journal of Cardiac Failure|March 14, 2013
The Singapore Heart Failure Outcomes and Phenotypes (SHOP) study and Prospective Evaluation of Outcome in Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction (PEOPLE) study: rationale and designRajalakshmi Santhanakrishnan, Tze P Ng, Vicky A Cameron, et al.
The New Zealand Medical Journal|August 18, 2018
Genomic medicine must reduce, not compound, health inequities: the case for hauora-enhancing genomic resources for New ZealandStephen P Robertson, Jennie Harre Hindmarsh, Sarah Berry, et al.
Heart (British Cardiac Society)|February 14, 2023
Prognostic modelling of clinical outcomes after first-time acute coronary syndrome in New ZealandNikki J Earle, Katrina K Poppe, Anna Rolleston, et al.
Atherosclerosis|September 17, 2025
Lipoprotein(a) concentrations and secondary outcomes following first-time acute coronary syndrome: The Multi-Ethnic New Zealand Study of Acute Coronary Syndromes (MENZACS)Malcolm E Legget, Nikki J Earle, Katrina K Poppe, et al.
Journal of the American College of Cardiology|March 23, 2019
Combining Circulating MicroRNA and NT-proBNP to Detect and Categorize Heart Failure SubtypesLee Lee Wong, Ruiyang Zou, Lihan Zhou, et al.
Journal of the American College of Cardiology|January 29, 2013
Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysisKenneth Chan, Riyaz S Patel, Paul Newcombe, et al.
European Heart Journal|March 22, 2021
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortalityStefan J Schunk, Marcus E Kleber, Winfried März, et al.
Circulation|July 14, 2020
Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant DataBakhtawar K Mahmoodi, Vinicius Tragante, Marcus E Kleber, et al.
Pageof 8